Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-10-22 | New | $36,495,008 | $36,495,008 | Equity Only | 06b | SEC link |
| 2023-11-22 | New | $78,950,836 | $78,950,836 | Equity Only | 06b | SEC link |
| 2013-09-10 | New | Yet to Sell | $0 | Equity Only | 05 46 | SEC link |
| Name | Role |
|---|---|
| Robert Braun | Director |
| Andrew J. Buckler | Executive |
| Shamiram Feinglass | Director |
| Kelly Huang | Director, Executive |
| Scott Huennekens | Director |
| Richard Kuntz | Director |
| Michael Lesh | Director |
| Evan Melrose | Director |
| Rajesh Panda | Director |
| Blake Richards | Executive |